Global Nonalcoholic Steatohepatitis (NASH) Market Research Report 2018

June 2018 | 100 pages | ID: G94852AC043EN
QYResearch

Abstracts

This report studies the global Nonalcoholic Steatohepatitis (NASH) market status and forecast, categorizes the global Nonalcoholic Steatohepatitis (NASH) market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

The global Nonalcoholic Steatohepatitis (NASH) market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.

The major manufacturers covered in this report

• Boehringer Ingelheim
• Cerenis Therapeutics
• Connexios Life Sciences
• Genfit
• Islet Sciences
• Nimbus Therapeutics
• Verva Pharmaceuticals
• Viking Therapeutics
• Astazeneca Plc
• Galmed Pharmaceuticals
• GENFIT SA
• Gilead Science
• Novo Nordisk
• Immuron
• Intercepts Pharmaceuticals
• Enzo Biochem
• Tobira Therapeutics

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

We can also provide the customized separate regional or country-level reports, for the following regions:

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Singapore
• Rest of Asia-Pacific
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe
• Central & South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Saudi Arabia
• Turkey
• Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Weight Loss Treatment
• Insulin-Sensitizing Agents
• Lipid-Lowering Drugs
• Antioxidants
• Other

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

• Hospitals
• Clinics
• Research Institute
• Other

The study objectives of this report are:

• To analyze and study the global Nonalcoholic Steatohepatitis (NASH) sales, value, status (2013-2017) and forecast (2018-2025).
• Focuses on the key Nonalcoholic Steatohepatitis (NASH) manufacturers, to study the sales, value, market share and development plans in future.
• Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
• To define, describe and forecast the market by type, application and region.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
• To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Nonalcoholic Steatohepatitis (NASH) are as follows:

• History Year: 2013-2017
• Base Year: 2017
• Estimated Year: 2018
• Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Nonalcoholic Steatohepatitis (NASH) Manufacturers
Nonalcoholic Steatohepatitis (NASH) Distributors/Traders/Wholesalers
Nonalcoholic Steatohepatitis (NASH) Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations

• With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
• Regional and country-level analysis of the Nonalcoholic Steatohepatitis (NASH) market, by end-use.
• Detailed analysis and profiles of additional market players.

Contents

Global Nonalcoholic Steatohepatitis (NASH) Market Research Report 2018

1 NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET OVERVIEW

1.1 Product Overview and Scope of Nonalcoholic Steatohepatitis (NASH)
1.2 Nonalcoholic Steatohepatitis (NASH) Segment by Type (Product Category)
  1.2.1 Global Nonalcoholic Steatohepatitis (NASH) Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
  1.2.2 Global Nonalcoholic Steatohepatitis (NASH) Production Market Share by Type (Product Category) in 2017
  1.2.3 Weight Loss Treatment
  1.2.4 Insulin-Sensitizing Agents
  1.2.5 Lipid-Lowering Drugs
  1.2.6 Antioxidants
  1.2.7 Other
1.3 Global Nonalcoholic Steatohepatitis (NASH) Segment by Application
  1.3.1 Nonalcoholic Steatohepatitis (NASH) Consumption (Sales) Comparison by Application (2013-2025)
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Research Institute
  1.3.5 Other
1.4 Global Nonalcoholic Steatohepatitis (NASH) Market by Region (2013-2025)
  1.4.1 Global Nonalcoholic Steatohepatitis (NASH) Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
  1.4.2 North America Status and Prospect (2013-2025)
  1.4.3 Europe Status and Prospect (2013-2025)
  1.4.4 China Status and Prospect (2013-2025)
  1.4.5 Japan Status and Prospect (2013-2025)
  1.4.6 Southeast Asia Status and Prospect (2013-2025)
  1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Nonalcoholic Steatohepatitis (NASH) (2013-2025)
  1.5.1 Global Nonalcoholic Steatohepatitis (NASH) Revenue Status and Outlook (2013-2025)
  1.5.2 Global Nonalcoholic Steatohepatitis (NASH) Capacity, Production Status and Outlook (2013-2025)

2 GLOBAL NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET COMPETITION BY MANUFACTURERS

2.1 Global Nonalcoholic Steatohepatitis (NASH) Capacity, Production and Share by Manufacturers (2013-2018)
  2.1.1 Global Nonalcoholic Steatohepatitis (NASH) Capacity and Share by Manufacturers (2013-2018)
  2.1.2 Global Nonalcoholic Steatohepatitis (NASH) Production and Share by Manufacturers (2013-2018)
2.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue and Share by Manufacturers (2013-2018)
2.3 Global Nonalcoholic Steatohepatitis (NASH) Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Nonalcoholic Steatohepatitis (NASH) Manufacturing Base Distribution, Sales Area and Product Type
2.5 Nonalcoholic Steatohepatitis (NASH) Market Competitive Situation and Trends
  2.5.1 Nonalcoholic Steatohepatitis (NASH) Market Concentration Rate
  2.5.2 Nonalcoholic Steatohepatitis (NASH) Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL NONALCOHOLIC STEATOHEPATITIS (NASH) CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2013-2018)

3.1 Global Nonalcoholic Steatohepatitis (NASH) Capacity and Market Share by Region (2013-2018)
3.2 Global Nonalcoholic Steatohepatitis (NASH) Production and Market Share by Region (2013-2018)
3.3 Global Nonalcoholic Steatohepatitis (NASH) Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Nonalcoholic Steatohepatitis (NASH) Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Nonalcoholic Steatohepatitis (NASH) Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Nonalcoholic Steatohepatitis (NASH) Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Nonalcoholic Steatohepatitis (NASH) Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Nonalcoholic Steatohepatitis (NASH) Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Nonalcoholic Steatohepatitis (NASH) Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 GLOBAL NONALCOHOLIC STEATOHEPATITIS (NASH) SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2013-2018)

4.1 Global Nonalcoholic Steatohepatitis (NASH) Consumption by Region (2013-2018)
4.2 North America Nonalcoholic Steatohepatitis (NASH) Production, Consumption, Export, Import (2013-2018)
4.3 Europe Nonalcoholic Steatohepatitis (NASH) Production, Consumption, Export, Import (2013-2018)
4.4 China Nonalcoholic Steatohepatitis (NASH) Production, Consumption, Export, Import (2013-2018)
4.5 Japan Nonalcoholic Steatohepatitis (NASH) Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Production, Consumption, Export, Import (2013-2018)
4.7 India Nonalcoholic Steatohepatitis (NASH) Production, Consumption, Export, Import (2013-2018)

5 GLOBAL NONALCOHOLIC STEATOHEPATITIS (NASH) PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Nonalcoholic Steatohepatitis (NASH) Production and Market Share by Type (2013-2018)
5.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue and Market Share by Type (2013-2018)
5.3 Global Nonalcoholic Steatohepatitis (NASH) Price by Type (2013-2018)
5.4 Global Nonalcoholic Steatohepatitis (NASH) Production Growth by Type (2013-2018)

6 GLOBAL NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET ANALYSIS BY APPLICATION

6.1 Global Nonalcoholic Steatohepatitis (NASH) Consumption and Market Share by Application (2013-2018)
6.2 Global Nonalcoholic Steatohepatitis (NASH) Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL NONALCOHOLIC STEATOHEPATITIS (NASH) MANUFACTURERS PROFILES/ANALYSIS

7.1 Boehringer Ingelheim
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Boehringer Ingelheim Nonalcoholic Steatohepatitis (NASH) Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.1.4 Main Business/Business Overview
7.2 Cerenis Therapeutics
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Cerenis Therapeutics Nonalcoholic Steatohepatitis (NASH) Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.2.4 Main Business/Business Overview
7.3 Connexios Life Sciences
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Connexios Life Sciences Nonalcoholic Steatohepatitis (NASH) Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.3.4 Main Business/Business Overview
7.4 Genfit
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Genfit Nonalcoholic Steatohepatitis (NASH) Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.4.4 Main Business/Business Overview
7.5 Islet Sciences
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Islet Sciences Nonalcoholic Steatohepatitis (NASH) Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
  7.5.4 Main Business/Business Overview
7.6 Nimbus Therapeutics
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Nimbus Therapeutics Nonalcoholic Steatohepatitis (NASH) Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.6.4 Main Business/Business Overview
7.7 Verva Pharmaceuticals
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Verva Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.7.4 Main Business/Business Overview
7.8 Viking Therapeutics
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Viking Therapeutics Nonalcoholic Steatohepatitis (NASH) Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.8.4 Main Business/Business Overview
7.9 Astazeneca Plc
  7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.9.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Astazeneca Plc Nonalcoholic Steatohepatitis (NASH) Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.9.4 Main Business/Business Overview
7.10 Galmed Pharmaceuticals
  7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.10.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Capacity, Production, Revenue, Price and Gross Margin (2013-2020)
  7.10.4 Main Business/Business Overview
7.11 GENFIT SA
7.12 Gilead Science
7.13 Novo Nordisk
7.14 Immuron
7.15 Intercepts Pharmaceuticals
7.16 Enzo Biochem
7.17 Tobira Therapeutics

8 NONALCOHOLIC STEATOHEPATITIS (NASH) MANUFACTURING COST ANALYSIS

8.1 Nonalcoholic Steatohepatitis (NASH) Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Nonalcoholic Steatohepatitis (NASH)

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Nonalcoholic Steatohepatitis (NASH) Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Nonalcoholic Steatohepatitis (NASH) Major Manufacturers in 2017
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET FORECAST (2018-2025)

12.1 Global Nonalcoholic Steatohepatitis (NASH) Capacity, Production, Revenue Forecast (2018-2025)
  12.1.1 Global Nonalcoholic Steatohepatitis (NASH) Capacity, Production and Growth Rate Forecast (2018-2025)
  12.1.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate Forecast (2018-2025)
  12.1.3 Global Nonalcoholic Steatohepatitis (NASH) Price and Trend Forecast (2018-2025)
12.2 Global Nonalcoholic Steatohepatitis (NASH) Production, Consumption, Import and Export Forecast by Region (2018-2025)
  12.2.1 North America Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.2 Europe Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.3 China Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.4 Japan Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.5 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.6 India Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Nonalcoholic Steatohepatitis (NASH) Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Nonalcoholic Steatohepatitis (NASH) Consumption Forecast by Application (2018-2025)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Nonalcoholic Steatohepatitis (NASH)
Figure Global Nonalcoholic Steatohepatitis (NASH) Production () and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Nonalcoholic Steatohepatitis (NASH) Production Market Share by Types (Product Category) in 2017
Figure Product Picture of Weight Loss Treatment
Table Major Manufacturers of Weight Loss Treatment
Figure Product Picture of Insulin-Sensitizing Agents
Table Major Manufacturers of Insulin-Sensitizing Agents
Figure Product Picture of Lipid-Lowering Drugs
Table Major Manufacturers of Lipid-Lowering Drugs
Figure Product Picture of Antioxidants
Table Major Manufacturers of Antioxidants
Figure Product Picture of Other
Table Major Manufacturers of Other
Figure Global Nonalcoholic Steatohepatitis (NASH) Consumption (K Pcs) by Applications (2013-2025)
Figure Global Nonalcoholic Steatohepatitis (NASH) Consumption Market Share by Applications in 2017
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Research Institute Examples
Table Key Downstream Customer in Research Institute
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global Nonalcoholic Steatohepatitis (NASH) Market Size (Million USD), Comparison (K Pcs) and CAGR (%) by Regions (2013-2025)
Figure North America Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) Status and Outlook (2013-2025)
Figure Global Nonalcoholic Steatohepatitis (NASH) Capacity, Production (K Pcs) Status and Outlook (2013-2025)
Figure Global Nonalcoholic Steatohepatitis (NASH) Major Players Product Capacity (K Pcs) (2013-2018)
Table Global Nonalcoholic Steatohepatitis (NASH) Capacity (K Pcs) of Key Manufacturers (2013-2018)
Table Global Nonalcoholic Steatohepatitis (NASH) Capacity Market Share of Key Manufacturers (2013-2018)
Figure Global Nonalcoholic Steatohepatitis (NASH) Capacity (K Pcs) of Key Manufacturers in 2017
Figure Global Nonalcoholic Steatohepatitis (NASH) Capacity (K Pcs) of Key Manufacturers in 2018
Figure Global Nonalcoholic Steatohepatitis (NASH) Major Players Product Production (K Pcs) (2013-2018)
Table Global Nonalcoholic Steatohepatitis (NASH) Production (K Pcs) of Key Manufacturers (2013-2018)
Table Global Nonalcoholic Steatohepatitis (NASH) Production Share by Manufacturers (2013-2018)
Figure 2017 Nonalcoholic Steatohepatitis (NASH) Production Share by Manufacturers
Figure 2017 Nonalcoholic Steatohepatitis (NASH) Production Share by Manufacturers
Figure Global Nonalcoholic Steatohepatitis (NASH) Major Players Product Revenue (Million USD) (2013-2018)
Table Global Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) by Manufacturers (2013-2018)
Table Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Manufacturers (2013-2018)
Table 2017 Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Manufacturers
Table 2018 Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Manufacturers
Table Global Market Nonalcoholic Steatohepatitis (NASH) Average Price (USD/Pcs) of Key Manufacturers (2013-2018)
Figure Global Market Nonalcoholic Steatohepatitis (NASH) Average Price (USD/Pcs) of Key Manufacturers in 2017
Table Manufacturers Nonalcoholic Steatohepatitis (NASH) Manufacturing Base Distribution and Sales Area
Table Manufacturers Nonalcoholic Steatohepatitis (NASH) Product Category
Figure Nonalcoholic Steatohepatitis (NASH) Market Share of Top 3 Manufacturers
Figure Nonalcoholic Steatohepatitis (NASH) Market Share of Top 5 Manufacturers
Table Global Nonalcoholic Steatohepatitis (NASH) Capacity (K Pcs) by Region (2013-2018)
Figure Global Nonalcoholic Steatohepatitis (NASH) Capacity Market Share by Region (2013-2018)
Figure Global Nonalcoholic Steatohepatitis (NASH) Capacity Market Share by Region (2013-2018)
Figure 2017 Global Nonalcoholic Steatohepatitis (NASH) Capacity Market Share by Region
Table Global Nonalcoholic Steatohepatitis (NASH) Production by Region (2013-2018)
Figure Global Nonalcoholic Steatohepatitis (NASH) Production (K Pcs) by Region (2013-2018)
Figure Global Nonalcoholic Steatohepatitis (NASH) Production Market Share by Region (2013-2018)
Figure 2017 Global Nonalcoholic Steatohepatitis (NASH) Production Market Share by Region
Table Global Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) by Region (2013-2018)
Table Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Region (2013-2018)
Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Region (2013-2018)
Table 2017 Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Region
Figure Global Nonalcoholic Steatohepatitis (NASH) Capacity, Production (K Pcs) and Growth Rate (2013-2018)
Table Global Nonalcoholic Steatohepatitis (NASH) Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table North America Nonalcoholic Steatohepatitis (NASH) Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table Europe Nonalcoholic Steatohepatitis (NASH) Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table China Nonalcoholic Steatohepatitis (NASH) Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table Japan Nonalcoholic Steatohepatitis (NASH) Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table China Nonalcoholic Steatohepatitis (NASH) Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table Japan Nonalcoholic Steatohepatitis (NASH) Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table Global Nonalcoholic Steatohepatitis (NASH) Consumption (K Pcs) Market by Region (2013-2018)
Table Global Nonalcoholic Steatohepatitis (NASH) Consumption Market Share by Region (2013-2018)
Figure Global Nonalcoholic Steatohepatitis (NASH) Consumption Market Share by Region (2013-2018)
Figure 2017 Global Nonalcoholic Steatohepatitis (NASH) Consumption (K Pcs) Market Share by Region
Table North America Nonalcoholic Steatohepatitis (NASH) Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table Europe Nonalcoholic Steatohepatitis (NASH) Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table China Nonalcoholic Steatohepatitis (NASH) Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table Japan Nonalcoholic Steatohepatitis (NASH) Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table Southeast Asia Nonalcoholic Steatohepatitis (NASH) Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table India Nonalcoholic Steatohepatitis (NASH) Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table Global Nonalcoholic Steatohepatitis (NASH) Production (K Pcs) by Type (2013-2018)
Table Global Nonalcoholic Steatohepatitis (NASH) Production Share by Type (2013-2018)
Figure Production Market Share of Nonalcoholic Steatohepatitis (NASH) by Type (2013-2018)
Figure 2017 Production Market Share of Nonalcoholic Steatohepatitis (NASH) by Type
Table Global Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) by Type (2013-2018)
Table Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Nonalcoholic Steatohepatitis (NASH) by Type (2013-2018)
Figure 2017 Revenue Market Share of Nonalcoholic Steatohepatitis (NASH) by Type
Table Global Nonalcoholic Steatohepatitis (NASH) Price (USD/Pcs) by Type (2013-2018)
Figure Global Nonalcoholic Steatohepatitis (NASH) Production Growth by Type (2013-2018)
Table Global Nonalcoholic Steatohepatitis (NASH) Consumption (K Pcs) by Application (2013-2018)
Table Global Nonalcoholic Steatohepatitis (NASH) Consumption Market Share by Application (2013-2018)
Figure Global Nonalcoholic Steatohepatitis (NASH) Consumption Market Share by Applications (2013-2018)
Figure Global Nonalcoholic Steatohepatitis (NASH) Consumption Market Share by Application in 2017
Table Global Nonalcoholic Steatohepatitis (NASH) Consumption Growth Rate by Application (2013-2018)
Figure Global Nonalcoholic Steatohepatitis (NASH) Consumption Growth Rate by Application (2013-2018)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim Nonalcoholic Steatohepatitis (NASH) Capacity, Production (K Pcs), Revenue (Million USD), Price (Boehringer Ingelheim) and Gross Margin (2013-2018)
Figure Boehringer Ingelheim Nonalcoholic Steatohepatitis (NASH) Production Growth Rate (2013-2018)
Figure Boehringer Ingelheim Nonalcoholic Steatohepatitis (NASH) Production Market Share (2013-2018)
Figure Boehringer Ingelheim Nonalcoholic Steatohepatitis (NASH) Revenue Market Share (2013-2018)
Table Cerenis Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cerenis Therapeutics Nonalcoholic Steatohepatitis (NASH) Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Cerenis Therapeutics Nonalcoholic Steatohepatitis (NASH) Production Growth Rate (2013-2018)
Figure Cerenis Therapeutics Nonalcoholic Steatohepatitis (NASH) Production Market Share (2013-2018)
Figure Cerenis Therapeutics Nonalcoholic Steatohepatitis (NASH) Revenue Market Share (2013-2018)
Table Connexios Life Sciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Connexios Life Sciences Nonalcoholic Steatohepatitis (NASH) Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Connexios Life Sciences Nonalcoholic Steatohepatitis (NASH) Production Growth Rate (2013-2018)
Figure Connexios Life Sciences Nonalcoholic Steatohepatitis (NASH) Production Market Share (2013-2018)
Figure Connexios Life Sciences Nonalcoholic Steatohepatitis (NASH) Revenue Market Share (2013-2018)
Table Genfit Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Genfit Nonalcoholic Steatohepatitis (NASH) Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Genfit Nonalcoholic Steatohepatitis (NASH) Production Growth Rate (2013-2018)
Figure Genfit Nonalcoholic Steatohepatitis (NASH) Production Market Share (2013-2018)
Figure Genfit Nonalcoholic Steatohepatitis (NASH) Revenue Market Share (2013-2018)
Table Islet Sciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Islet Sciences Nonalcoholic Steatohepatitis (NASH) Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Islet Sciences Nonalcoholic Steatohepatitis (NASH) Production Growth Rate (2013-2018)
Figure Islet Sciences Nonalcoholic Steatohepatitis (NASH) Production Market Share (2013-2018)
Figure Islet Sciences Nonalcoholic Steatohepatitis (NASH) Revenue Market Share (2013-2018)
Table Nimbus Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Nimbus Therapeutics Nonalcoholic Steatohepatitis (NASH) Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Nimbus Therapeutics Nonalcoholic Steatohepatitis (NASH) Production Growth Rate (2013-2018)
Figure Nimbus Therapeutics Nonalcoholic Steatohepatitis (NASH) Production Market Share (2013-2018)
Figure Nimbus Therapeutics Nonalcoholic Steatohepatitis (NASH) Revenue Market Share (2013-2018)
Table Verva Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Verva Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Verva Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Production Growth Rate (2013-2018)
Figure Verva Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Production Market Share (2013-2018)
Figure Verva Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue Market Share (2013-2018)
Table Viking Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Viking Therapeutics Nonalcoholic Steatohepatitis (NASH) Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Viking Therapeutics Nonalcoholic Steatohepatitis (NASH) Production Growth Rate (2013-2018)
Figure Viking Therapeutics Nonalcoholic Steatohepatitis (NASH) Production Market Share (2013-2018)
Figure Viking Therapeutics Nonalcoholic Steatohepatitis (NASH) Revenue Market Share (2013-2018)
Table Astazeneca Plc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astazeneca Plc Nonalcoholic Steatohepatitis (NASH) Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Astazeneca Plc Nonalcoholic Steatohepatitis (NASH) Production Growth Rate (2013-2018)
Figure Astazeneca Plc Nonalcoholic Steatohepatitis (NASH) Production Market Share (2013-2018)
Figure Astazeneca Plc Nonalcoholic Steatohepatitis (NASH) Revenue Market Share (2013-2018)
Table Galmed Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Production Growth Rate (2013-2018)
Figure Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Production Market Share (2013-2018)
Figure Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nonalcoholic Steatohepatitis (NASH)
Figure Manufacturing Process Analysis of Nonalcoholic Steatohepatitis (NASH)
Figure Nonalcoholic Steatohepatitis (NASH) Industrial Chain Analysis
Table Raw Materials Sources of Nonalcoholic Steatohepatitis (NASH) Major Manufacturers in 2017
Table Major Buyers of Nonalcoholic Steatohepatitis (NASH)
Table Distributors/Traders List
Figure Global Nonalcoholic Steatohepatitis (NASH) Capacity, Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Nonalcoholic Steatohepatitis (NASH) Price (Million USD) and Trend Forecast (2018-2025)
Table Global Nonalcoholic Steatohepatitis (NASH) Production (K Pcs) Forecast by Region (2018-2025)
Figure Global Nonalcoholic Steatohepatitis (NASH) Production Market Share Forecast by Region (2018-2025)
Table Global Nonalcoholic Steatohepatitis (NASH) Consumption (K Pcs) Forecast by Region (2018-2025)
Figure Global Nonalcoholic Steatohepatitis (NASH) Consumption Market Share Forecast by Region (2018-2025)
Figure North America Nonalcoholic Steatohepatitis (NASH) Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure North America Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table North America Nonalcoholic Steatohepatitis (NASH) Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Europe Nonalcoholic Steatohepatitis (NASH) Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure China Nonalcoholic Steatohepatitis (NASH) Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure China Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table China Nonalcoholic Steatohepatitis (NASH) Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure Japan Nonalcoholic Steatohepatitis (NASH) Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Japan Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Japan Nonalcoholic Steatohepatitis (NASH) Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure Southeast Asia Nonalcoholic Steatohepatitis (NASH) Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Southeast Asia Nonalcoholic Steatohepatitis (NASH) Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure India Nonalcoholic Steatohepatitis (NASH) Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure India Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table India Nonalcoholic Steatohepatitis (NASH) Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Table Global Nonalcoholic Steatohepatitis (NASH) Production (K Pcs) Forecast by Type (2018-2025)
Figure Global Nonalcoholic Steatohepatitis (NASH) Production (K Pcs) Forecast by Type (2018-2025)
Table Global Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share Forecast by Type (2018-2025)
Table Global Nonalcoholic Steatohepatitis (NASH) Price Forecast by Type (2018-2025)
Table Global Nonalcoholic Steatohepatitis (NASH) Consumption (K Pcs) Forecast by Application (2018-2025)
Figure Global Nonalcoholic Steatohepatitis (NASH) Consumption (K Pcs) Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source